vs
Side-by-side financial comparison of CONMED Corp (CNMD) and Integer Holdings Corp (ITGR). Click either name above to swap in a different company.
The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices in...
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $373.2M | — | ||
| Q3 25 | $337.9M | — | ||
| Q2 25 | $342.3M | — | ||
| Q1 25 | $321.3M | — | ||
| Q4 24 | $345.9M | — | ||
| Q3 24 | $316.7M | — | ||
| Q2 24 | $332.1M | — | ||
| Q1 24 | $312.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | $21.4M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $49.0M | — | ||
| Q2 24 | $30.0M | — | ||
| Q1 24 | $19.7M | — |
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | — | ||
| Q2 25 | 55.0% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 56.5% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 55.1% | — |
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | 11.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.5% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | 6.3% | — |
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.69 | — | ||
| Q1 25 | $0.19 | — | ||
| Q4 24 | $1.09 | — | ||
| Q3 24 | $1.57 | — | ||
| Q2 24 | $0.96 | — | ||
| Q1 24 | $0.63 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
